Verilife Cleared To Sell First Cannabis Home Grow Kits In New York

Verilife, a private Buffalo, New York dispensary owned by PharmaCann, Inc. will become the first location in the state to sell immature plant clones to certified medical cannabis patients and caregivers to grow in their home.

“New York’s certified patients have waited for this opportunity, and we could not be more excited for Verilife to lead New York’s medical cannabis industry into this new era,” said Jeremy Unruh, senior vice president of public and regulatory affairs for Verilife.

Verilife said in a news release that the company had spent months working with the Office of Cannabis Management (OCM) to provide home grow starter stock. The company added that ability to grow at home will make it more affordable for patients to have access to long-term treatment and relief.

The news comes a month after the New York Cannabis Control Board issued regulations to govern medical cannabis home cultivation allowing registered patients to grow as many as six plants of their own and for caregivers to grow up to 12 plants.

New York’s MMJ program had previously prohibited home cultivation.

New York regulations allow patients 21 years of age or older, with proper designation, to grow up to three mature and three immature cannabis plants at a given time. The state will also allow a designated caregiver for multiple patients to grow up to twice that amount of both immature and mature cannabis plants.

Verilife home cultivation clone strains include Lavender, Pineapple Super Silver Haze and Pink Lemonade. The company said that clones are available on a first-come, first-served basis at Verilife’s Amherst location while supplies last. All sales of medical plant matter are final.

Clones will eventually be available in more locations throughout the state.

“Verilife has been leading the charge in New York since day one,” said Unruh. “We were the first regulated cannabis operator licensed in the Empire State. We were the first to deliver regulated medical cannabis products to homebound medical patients. We were the first to wholesale our products to other medical dispensaries. Our patients know they can count on Verilife for best-in-class, safe and reliable products.”

It is one of the few aspects of the New York cannabis program that seems to be showing signs of progress. The adult-use program remains undefined by any established rules or regulations and the illicit market continues to be become more entrenched every day.

Adam Jackson

Adam Jackson covers the cannabis industry for The Green Market Report. He previously covered the Missouri statehouse for The Columbia Missourian and has written for The Missouri Independent. He most recently covered retail, restaurants, and other consumer companies for Bloomberg Business News. You can find him on Twitter @adam_sjackson and email him at adam.jackson@crain.com.


Agrify

Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 7 hours

Pritzker Names New Cannabis Chief

@GreenMarketRpt – 7 hours

Red White & Bloom Keeps Debt at Bay – For Now

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.